Aids in differentiation of inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS) and other functional disorders of the gastrointestinal (GI) system. Aids in monitoring IBD and prediction of relapse.
Quantitative Chemiluminescent Immunoassay
New York DOH Approval Status
Transfer 5 g stool to an unpreserved stool transport vial (ARUP Supply #40910). Available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. (Min: 1 g)
Specimens in media or preservatives.
Ambient: Unacceptable; Refrigerated: 7 days; Frozen: 30 days
|49 µg/g or less||Normal|
|50-120 µg/g||Borderline elevated, test should be re-evaluated in 4-6 weeks.|
Fecal Calprotectin is an indicator of the presence of neutrophils in stool and is not specific for IBD. Other intestinal ailments including GI infections and colorectal cancer can result in elevated concentrations of calprotectin. The diagnosis of IBD cannot be established solely on the basis of a positive calprotectin result. Patients with IBD fluctuate between active and inactive stages of disease. Calprotectin results may also fluctuate.
|Component Test Code*||Component Chart Name||LOINC|
- Cal pro
- Fecal Calprotectin
- Stool Calprotectin